Vimarsana
Biggest News Aggregation in the World

John Puziss News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Puziss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Puziss Today - Breaking & Trending Today

Allyx Therapeutics Announces License For The Treatment of Cognitive Deficits in Neurodegenerative Disorders From Bristol Myers Squibb And Yale - Vimarsana News

Allyx Therapeutics Announces License For The Treatment of Cognitive Deficits in Neurodegenerative Disorders From Bristol Myers Squibb And Yale

Allyx Therapeutics Announces License For The Treatment of Cognitive Deficits in Neurodegenerative Disorders From Bristol Myers Squibb And Yale Share Article Allyx Therapeutics expects to advance ALX-001, an mGluR5 modulator for Alzheimer’s disease, into clinical trials in 2021 NEW HAVEN, Conn. (PRWEB) January 13, 2021 Today, Allyx Therapeutics announced the completion of a license agreement with Bristol Myers Squibb to develop Allyx’s novel therapy for Alzheimer’s disease. The agreement includes a sublicense of certain ri...

Source: prweb.com